Byron Vaughn

Appearances

Lunch Breakout: C DIFF AND FMT
Date
May 6, 2023
Please note that this session requires an additional registration fee to attend…
Presenters
Byron Vaughn
Sahil Khanna
Mayo Clinic
Lawrence Leung
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Date
May 7, 2023
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Presenter
Daphne Moutsoglou
Speakers
Sharon Lopez
Lulu Chen
Christopher Staley
Alexander Khoruts
Byron Vaughn
PATIENT OUTCOMES OF INTESTINAL MICROBIOTA TRANSPLANTATION FOR SEVERE AND FULMINANT CLOSTRIDIOIDES DIFFICILE INFECTION: RESULTS FROM A NATIONAL REGISTRY.
Date
May 18, 2024
INTRODUCTION: Intestinal microbiota transplantation (IMT) is an effective therapy for recurrent _Clostridioides difficile_ infection (rCDI) and a promising therapy for severe/fulminant CDI non-responsive to antibiotics…
Speakers
Byron Vaughn
Majdi Osman
Michael Bougas
Imani Decaille-Hodge
Laura Stehler
Presenter
Alexander Khoruts